HEALTH● LOW3d ago · Oct 29, 2026, 8:37 AM
Access to peptides eased despite FDA opposition
nwaonline · united states of america · north america
WASHINGTON -- The Trump administration on Wednesday acted to ease access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr. Food and Drug Administration scientific staffers had little input on the decision and opposed the changes, according to six people familiar with its development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapunited states of america and nearby eventsMore from united states of americaLatest stories and threat level
More in Health
HEALTH2h agoMeasles made a stealthy return as another virus took the spotlightNature NewsHEALTH3h agoMillions of popular coffee makers at Walmart, Target recalled after dozens burnedThe Independent WorldHEALTH4h agoDo you know signs of a stroke? BE FAST are the words to rememberNPR NewsHEALTH7h agoConnecticut Senator Chris Murphy is hospitalized with a strokeNPR News